Morgan Stanley Call 37.5 DWS 21.0.../ DE000ME4MV80 /
29/05/2024 20:31:23 | Var.- | Denaro09:11:05 | Lettera09:11:05 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.550EUR | - | 0.540 Quantità in denaro: 80,000 |
0.580 Quantità in lettera: 80,000 |
DWS GROUP GMBH+CO.KG... | 37.50 - | 21/06/2024 | Call |
GlobeNewswire
09:01
Persistent Systems Selects Zscaler to Launch Technology Modernization and Renewable Energy Initiativ...
GlobeNewswire
09:00
Curium Announces First Commercial Doses in France of Pylclari® – an Innovative 18F-Psma Pet Tracer I...
GlobeNewswire
09:00
Green Bioactives Reports Remarkable Cognitive Benefits of its Newly Launched Memory-boosting Nutrace...
GlobeNewswire
08:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
08:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
08:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
08:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
08:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents